State‐dependent regulation of the K v 7.2 channel voltage sensor by QO‐58
British Journal of Pharmacology · 2026-01 · 183 (2) · 333-348
DOI: 10.1111/bph.70186 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 12.09.2025. Verfasst von Richard Kanyo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: KCNQ2 Potassium Channel. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research postdoctoral fellowship, Alberta Innovates Summer Research Studentship.
Abstract (Originalsprache)
Background and Purpose K V 7(KCNQ) potassium channels are key modulators of neuronal excitability, and promising targets for development of drugs for epilepsy and pain. We investigated a candidate K V 7 drug, QO‐58, which has been previously described but has an unclear mechanism of action. Experimental Approach Targeted mutations or chimeric rearrangements of K V 7 channels were used to investigate potential sites of drug binding. K V 7 channels were expressed in Xenopus oocytes or HEK cells for electrophysiology and pharmacological characterisation. Key Results QO‐58 shares characteristic features of other voltage sensor domain (VSD)‐targeted potentiators. These include subtype specificity for K V 7.2 over K V 7.3, prominent state‐dependent actions, and marked deceleration of closure of K V 7.2. VSD mutations influence the actions of QO‐58 and another VSD‐targeted drug, ICA‐069673. Interestingly, K V 7.2[F168L] mutation, previously shown to abolish ICA‐069673 sensitivity, does not weaken QO‐58 actions. However, K V 7.2[F168W] reduces QO‐58 effects, while preserving sensitivity to ICA‐069673. This finding indicates subtle differences in the interaction of these drugs with the VSD binding site. Conclusions and Implications Key contacts underlying sensitivity to VSD‐targeted potentiators may vary significantly depending on the chemical and steric features of the drug. We anticipate that further investigation of VSD‐targeted drugs will continue to clarify the complex pharmacophore of the VSD binding pocket in K V 7 channels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.
ORCID-Profile: Richard Kanyo, Shawn M Lamothe, Harley T Kurata
Förderung
- CIHR
- Canadian Institutes of Health Research postdoctoral fellowship
- Alberta Innovates Summer Research Studentship
Zitieren
APA
Kanyo, R., Lamothe, S. M., Hammond, T. M., & Kurata, H. T. (2026). State‐dependent regulation of the K v 7.2 channel voltage sensor by QO‐58. British Journal of Pharmacology, 183(2), 333-348. https://doi.org/10.1111/bph.70186
Vancouver
Kanyo R, Lamothe SM, Hammond TM, Kurata HT. State‐dependent regulation of the K v 7.2 channel voltage sensor by QO‐58. British Journal of Pharmacology. 2026;183(2):333-348. doi:10.1111/bph.70186
BibTeX
@article{Kanyo2026,
author = {Kanyo, Richard and Lamothe, Shawn M and Hammond, Thomas M and Kurata, Harley T},
title = {State‐dependent regulation of the K v 7.2 channel voltage sensor by QO‐58},
journal = {British Journal of Pharmacology},
year = {2026},
volume = {183},
number = {2},
pages = {333--348},
doi = {10.1111/bph.70186}
}
EUVIMED